{"id":"placebo-levocetirizine","safety":{"commonSideEffects":[{"rate":"1-2%","effect":"Somnolence"},{"rate":"2-3%","effect":"Headache"},{"rate":"1-2%","effect":"Fatigue"},{"rate":"1-2%","effect":"Dry mouth"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levocetirizine is the active enantiomer of cetirizine, a second-generation antihistamine that selectively antagonizes peripheral H1 receptors. By blocking histamine binding to H1 receptors on mast cells, basophils, and endothelial cells, it reduces the release and effects of inflammatory mediators, thereby alleviating allergic symptoms without significant central nervous system penetration.","oneSentence":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:31.149Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Chronic urticaria"}]},"trialDetails":[{"nctId":"NCT05637710","phase":"PHASE3","title":"Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-03","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT03545464","phase":"PHASE3","title":"COrticosteroids in acUte uRticAria in emerGency dEpartment","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-21","conditions":"Urticaria, Angiœdema","enrollment":137},{"nctId":"NCT04699604","phase":"PHASE3","title":"A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)","status":"RECRUITING","sponsor":"Bridgette Jones","startDate":"2021-04-28","conditions":"Allergic Asthma","enrollment":300},{"nctId":"NCT05565729","phase":"PHASE1","title":"A Phase I Study of LY3471851 in Healthy Participants","status":"COMPLETED","sponsor":"Nektar Therapeutics","startDate":"2022-10-05","conditions":"Healthy","enrollment":41},{"nctId":"NCT00359138","phase":"PHASE4","title":"The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-02","conditions":"Hypersensitivity","enrollment":36},{"nctId":"NCT01392859","phase":"PHASE2, PHASE3","title":"Characterization of the Role of Histamine in Children With Asthma","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2011-06","conditions":"Asthma, Allergic Asthma, Non-allergic Asthma","enrollment":211},{"nctId":"NCT00621959","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Seasonal Allergic Rhinitis","enrollment":596},{"nctId":"NCT01586091","phase":"PHASE4","title":"Safety Study of Levocetirizine and Fexofenadine","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2011-02","conditions":"Pruritus, Chronic Urticaria, Allergic Rhinitis","enrollment":18},{"nctId":"NCT03991845","phase":"PHASE4","title":"A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-06-21","conditions":"Urticaria, Vitamin D Deficiency","enrollment":262},{"nctId":"NCT00679250","phase":"PHASE4","title":"To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis","status":"COMPLETED","sponsor":"Brian J Lipworth","startDate":"2005-11","conditions":"Allergic Rhinitis","enrollment":25},{"nctId":"NCT00152464","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)","status":"COMPLETED","sponsor":"UCB Pharma SA","startDate":"2002-03-20","conditions":"Dermatitis, Atopic","enrollment":514},{"nctId":"NCT02372604","phase":"PHASE3","title":"Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-07","conditions":"Chronic Spontaneous Urticaria","enrollment":15},{"nctId":"NCT00295022","phase":"PHASE4","title":"Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB S.A. - Pharma Sector","startDate":"2006-07-29","conditions":"Rhinitis, Allergic, Seasonal","enrollment":418},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT02447393","phase":"PHASE1","title":"Phase 1 Study of Levocetirizine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03-18","conditions":"Dermatitis","enrollment":20},{"nctId":"NCT00866788","phase":"PHASE2","title":"A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2009-03","conditions":"Chronic Idiopathic Urticaria","enrollment":90},{"nctId":"NCT01008592","phase":"","title":"The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism","status":"TERMINATED","sponsor":"Wake Forest University","startDate":"2009-04","conditions":"Rhinitis, Urticaria","enrollment":11},{"nctId":"NCT00619801","phase":"PHASE3","title":"Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Allergic Rhinitis, Chronic Urticaria","enrollment":173},{"nctId":"NCT00628108","phase":"PHASE3","title":"Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Allergic Rhinitis, Chronic Urticaria","enrollment":69},{"nctId":"NCT00160563","phase":"PHASE3","title":"Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)","status":"TERMINATED","sponsor":"UCB Pharma","startDate":"2004-06","conditions":"Asthma","enrollment":207},{"nctId":"NCT00150761","phase":"PHASE4","title":"Facial Thermography Study of Levocetirizine Versus Cetirizine","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-07","conditions":"Anti-allergic Agents","enrollment":60},{"nctId":"NCT00826943","phase":"PHASE4","title":"Is Levocetirizine Less Sedating Than Cetirizine?","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2009-01","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT00521170","phase":"PHASE1","title":"Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-11","conditions":"Allergy","enrollment":""},{"nctId":"NCT00160589","phase":"PHASE4","title":"LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-04","conditions":"Rhinitis, Allergic, Perennial","enrollment":729},{"nctId":"NCT00315523","phase":"PHASE3","title":"Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-07","conditions":"Rhinitis, Allergic, Seasonal","enrollment":403},{"nctId":"NCT01496911","phase":"PHASE4","title":"Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving","status":"COMPLETED","sponsor":"Utrecht Institute for Pharmaceutical Sciences","startDate":"2012-04","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT00884325","phase":"PHASE4","title":"Management of Pruritus With Xyzal in Atopic Dermatitis","status":"COMPLETED","sponsor":"Derm Research, PLLC","startDate":"2009-02","conditions":"Atopic Dermatitis, Pruritus","enrollment":40},{"nctId":"NCT01509209","phase":"PHASE3","title":"Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2011-05","conditions":"Vasomotor Rhinitis","enrollment":137},{"nctId":"NCT01640535","phase":"PHASE3","title":"Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2012-06","conditions":"Perennial Allergic Rhinitis","enrollment":283},{"nctId":"NCT00421109","phase":"PHASE3","title":"Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2006-07","conditions":"Urticaria","enrollment":522},{"nctId":"NCT00653224","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-04","conditions":"Seasonal Allergic Rhinitis","enrollment":580},{"nctId":"NCT00375713","phase":"PHASE3","title":"Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-10","conditions":"Dermatitis, Eczema","enrollment":466},{"nctId":"NCT00894231","phase":"PHASE4","title":"Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"AAADRS Clinical Research Center","startDate":"2009-01","conditions":"Perennial Allergic Rhinitis","enrollment":30},{"nctId":"NCT00355771","phase":"PHASE4","title":"Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis","status":"COMPLETED","sponsor":"Institut für Atemwegsforschung GmbH","startDate":"2006-06","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00439712","phase":"PHASE4","title":"Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Institut für Atemwegsforschung GmbH","startDate":"2007-02","conditions":"Perennial Allergic Rhinitis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo-Levocetirizine","genericName":"Placebo-Levocetirizine","companyName":"UCB Pharma","companyId":"ucb","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levocetirizine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses. Used for Allergic rhinitis, Chronic urticaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}